Graduate Institute of Clinical Medicine

Medicine & Life Sciences

1. Taiwan 100%
2. Meta-Analysis 35%
3. Neoplasms 34%
4. Stroke 30%
5. Cohort Studies 28%
6. Population 28%
7. Confidence Intervals 26%
8. Therapeutics 23%
9. Chronic Renal Insufficiency 22%
10. Apoptosis 20%
11. Randomized Controlled Trials 20%
12. Systematic Reviews 20%
13. Atrial Fibrillation 18%
14. Odds Ratio 18%
15. Pulmonary Veins 18%
16. Neoplasm Metastasis 17%
17. Breast Neoplasms 17%
18. Hepatocellular Carcinoma 17%
19. Genes 17%
20. Arsenic 17%
21. Kidney 17%
22. Mortality 16%
23. Colorectal Neoplasms 15%
24. Bipolar Disorder 15%
25. Proteins 14%
26. Renal Dialysis 14%
27. Biomarkers 14%
28. Down-Regulation 14%
29. Cardiac Myocytes 13%
30. Databases 12%
31. Incidence 12%
32. Lung 12%
33. Reactive Oxygen Species 12%
34. Wounds and Injuries 11%
35. Serum 11%
36. Lung Neoplasms 11%
37. Inflammation 11%
38. In Vitro Techniques 11%
39. Schizophrenia 11%
40. Growth 11%
41. Calcium 11%
42. Autophagy 11%
43. National Health Programs 11%
44. Survival 10%
45. MicroRNAs 10%
46. Neoplastic Stem Cells 10%
47. Gene Expression 10%
48. Chronic Obstructive Pulmonary Disease 10%
49. Prostatic Neoplasms 9%
50. Up-Regulation 9%
51. Carcinoma 9%
52. Drug Therapy 9%
53. Catenins 9%
54. Non-Small Cell Lung Carcinoma 9%
55. Sleep 9%
56. Methylation 9%
57. Oxidative Stress 8%
58. Metabolic Syndrome 8%
59. Endothelial Cells 8%
60. ErbB Receptors 8%
61. Epithelial-Mesenchymal Transition 8%
62. Lipopolysaccharides 8%
63. Hyperoxia 8%
64. Macrophages 8%
65. Mesenchymal Stem Cells 8%
66. Hypertension 8%
67. Heme Oxygenase-1 8%
68. Dialysis 8%
69. Retrospective Studies 8%
70. Cell Line 8%
71. Fibrosis 8%
72. Nitric Oxide 8%
73. Peroxisome Proliferator-Activated Receptors 8%
74. Recurrence 8%
75. Cell Proliferation 8%
76. Blood Pressure 8%
77. Cell Movement 8%
78. Case-Control Studies 8%
79. Pharmaceutical Preparations 7%
80. Mouth Neoplasms 7%
81. Safety 7%
82. Fibroblasts 7%
83. Colonic Neoplasms 7%
84. Diabetes Mellitus 7%
85. Glioblastoma 7%
86. Ovarian Neoplasms 7%
87. Chronic Kidney Failure 7%
88. Pneumonia 7%
89. Quality of Life 7%
90. Mutation 7%
91. Dementia 7%
92. Depression 7%
93. Messenger RNA 7%
94. Skin 7%
95. Liver 7%
96. Bone and Bones 7%
97. Triple Negative Breast Neoplasms 7%
98. Cardiovascular Diseases 7%
99. Heart Failure 6%
100. Logistic Models 6%